Intermolecular (IMI) Tops Q1 EPS by 1c

Intermolecular (NASDAQ: IMI) reported Q1 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.7 million.

GUIDANCE:

Intermolecular sees Q2 2018 EPS of $0.00-$0.01. Intermolecular sees Q2 2018 revenue of $9.8-10.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79